Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$925,960
+$390,654 QoQ
Shares Held
772
+32.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#3,211
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mathes Company, Inc. holds $5,421,408 across 7 Drug Manufacturers - General names. LLY ranks #3 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
48,623 | $1,170,841 | |
| 2 | AMGN |
Amgen Inc
|
3,095 | $1,120,761 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
772 | $925,960 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
5,500 | $694,870 | |
| 5 | JNJ |
Johnson & Johnson
|
2,641 | $670,734 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,565 | $586,602 | |
| 7 | ABBV |
AbbVie Inc.
|
1,000 | $251,640 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $925,960 | 772 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $535,306 | 582 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $625,463 | 582 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $444,066 | 582 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $339,095 | 435 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $780,484 | 945 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $432,320 | 560 | Shares | Sole | 2025-01-31 | |
| No filing history on record for this holder in this stock. | ||||||